Jane Street
DMK

Jane Street’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Jane Street’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,383
Closed -$16.4K – 10253
2022
Q4 		$16.4K Buy
+1,383
New +$15.8K ﹤0.01% 8652
2022
Q3 		– Sell
-249
Closed -$9K – 10719
2022
Q2 		$9K Buy
+249
New +$7.77K ﹤0.01% 9339
2022
Q1 		– Sell
-596
Closed -$25K – 11252
2021
Q4 		$25K Buy
596
+437
+275% +$27.3K ﹤0.01% 9746
2021
Q3 		$11K Buy
+159
New +$11.6K ﹤0.01% 9805
2021
Q2 		– Sell
-218
Closed -$13.3K – 10611
2021
Q1 		$15K Buy
+218
New +$17K ﹤0.01% 9001
2020
Q4 		– Sell
-290
Closed -$16K – 8285
2020
Q3 		$16K Sell
290
-240
-45% -$14.2K ﹤0.01% 7044
2020
Q2 		$20K Buy
+530
New +$18.1K ﹤0.01% 6968
2020
Q1 		– Sell
-243
Closed -$12K – 6162
2019
Q4 		$12K Buy
+243
New +$11.8K ﹤0.01% 4963
2019
Q1 		– Sell
-196
Closed -$31K – 5804
2018
Q4 		$31K Buy
+196
New +$37.6K ﹤0.01% 4757
2014
Q4 		– Sell
-153
Closed -$50K – 3152
2014
Q3 		$50K Sell
153
-85
-36% -$24.9K ﹤0.01% 2421
2014
Q2 		$80K Buy
238
+7
+3% +$2.75K ﹤0.01% 2388
2014
Q1 		$103K Buy
+231
New +$105K ﹤0.01% 2513

Other funds holding DMK

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street's DMK Position: Q1 2023 in Review

Jane Street sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2023, closing a stake of 1,383 shares — an estimated $16.4K sold.

Jane Street first reported a position in DMK in Q1 2014 and held it in 12 quarters. The position peaked at $103K in Q1 2014. 47 funds tracked by Wall St. Rank hold DMK as of Q1 2023.

  • Jane Street reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 1,383 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2023, an estimated $16.4K.
  • Jane Street first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q1 2014 and held it in 12 quarters.
  • Jane Street's DMK Pharmaceuticals Corporation Common Stock position peaked at $103K in Q1 2014.
  • 47 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.